Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES
Pharmas Market Video Gallery
Merck to share its outlook tomorrow, with CNBC's Mike Huckman and the Fast Money traders.
CNBC's Mike Huckman has the latest on a new heart drug study that could affect tens of millions of Americans.
PHARMA WATCH LIST
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
See all Pharmas Market PostsPharma's Market with Mike Huckman
Text Size
Aug.11
3:26 PM ET
Monday, 11 Aug 2008
Pfizer Breaks A Barrier

AP

Since some readers often accuse me of focusing on the bad news about Pfizer, I wanted to be sure and call attention to the fact that PFE is no longer a teenager.

Intraday, at least, shares of the Dow component have broken above $20--just barely, though. If the stock can stay there at 4 p.m. ET today, our resident stock statistician, Robert Hum, says that'll be the first time Pfizer's closed above that level since May 21st.

Coincidentally, Leerink Swann's big pharma analyst Seamus Fernandez is out with a research note to clients on PFE today. He's raising his sales and earnings forecasts for 2011 and 2012, but cutting his EPS projections for 2009 and 2010.

It's essentially a wash because Fernandez writes, "Still-negative outlook keeps us on the sidelines." He also thinks the big Pfizer dividend is "likely safe" through '12 as long as there are no "major shocks or mega-mergers". After 2012, Fernandez isn't so sure about the dividend. That's when the loss of the patent on the mega-blockbuster cholesterol drug will be in full effect.

Leerink Swann may trade in PFE [PFE  Loading...      ()   ].

Questions?  Comments? 

© 2008 CNBC, Inc. All Rights Reserved

Permalink: /id/26139788

HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC MOBILE  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis